TRANSCON — 1849180
Application number
1849180
Registration number
TMA1062896
Type(s)
Word
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2017-07-25
Registered
2019-11-13
Registration Expiry Date
2029-11-13
Registered Owner
ASCENDIS PHARMA A/S
Tuborg Boulevard 5
2900 Hellerup
DENMARK
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- TRANSCON
- TRANS CON
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical and veterinary preparations, including for physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, namely growth and thyroid disorder, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders, namely, intestinal infectious diseases, infections with a predominantly sexual mode of transmission, viral infections of the central nervous system, arthropod-borne viral fevers and viral haemorrhagic fevers, viral infections characterized by skin and mucous membrane lesions, human immunodeficiency virus [HIV] disease, mycoses, protozoal diseases, and helminthiases, enzyme replacement therapy, anti-inflammatory disease, the relief of pain, the treatment of chronic pain, the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries, respiratory system disorders, autoimmune disorders, vaccines for human and veterinary use; human and veterinary vaccine preparations, human and veterinary vaccines, non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, and multiple sclerosis, bone diseases, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous systems movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, and brain movement diseases, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy, cachexia, metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement ; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes; dietetic substances adapted for medical use, namely, dietetic sugar substitutes adapted for medical use; all-purpose disinfectants for sanitary purposes; fungicides; herbicides
Services (Nice class & Statement)
- 42
- (1) Scientific research within the medical, pharmaceutical and bacteriological area, including consultancy and information relating thereto; conducting of tests regarding medical applications; packaging design for pharmaceutical preparations; designing and development of medical equipment; designing pharmaceutical and medical preparations; preparation of pharmaceutical formulations; design and development of granulation technology and tablet technology, including consultancy and information relating thereto
- 45
- (2) Licensing of industrial property; legal services
Claims
- Priority Filing Date: February 24, 2017, Country or Office: EUIPO (EU), Application No. 016407983 in association with the same kind of goods and in association with the same kind of services
- Proposed Use in CANADA
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2017-07-25 | ||
| Created | 2017-07-26 | ||
| Formalized | 2017-08-01 | ||
| Search Recorded | 2018-07-06 | ||
| Examiner's First Report | 2018-07-06 | 2019-01-06 | |
| Approval Notice Sent | 2019-05-08 | 2019-06-05 | |
| Approved | 2019-06-27 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2019-07-17 | Vol.66 Issue 3377 | |
| Agent Name Changed | 2019-09-11 | ||
| Registration Pending | 2019-10-09 | ||
| Registration Fee Notice Sent | 2019-10-09 | 2020-04-09 | |
| Registered | 2019-11-13 | 2029-11-13 | |
| Agent Changed | 2022-10-07 | From: 26 To: 12 | |
| Agent Changed | 2026-04-21 | Transferred From: 12 To: 59 |